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The clinical significance of rapid self-terminating ventricu- 
lar tachycardia induced during electrophysiologic study 
was prospectively evaluated in three patient groups with 
clinical ventricular arrhythmias. Group A (11 patients) had 
inducible rapid self-terminating ventricular tachycardia 
only (mean cycle length 5250 ms and 110 heats in dura- 
tion). In Group B (22 patients) induction of this arrhythmia 
was followed by the induction of sustained ventricular 
tachycardia. In Group C (82 patients) sustained ventricular 
tachycardia was induced without preceding rapid self- 
terminating ventricular tachycardia. 
All clinical characteristics of Group B patients were 
similar to those of Group C patients but differed markedly 
from those of Group A patients. Compared with Group A 
patients, Group B patients had a lower left ventricular 
ejection fraction (32 f 13% versus 52 + 17%, p = 0.004j 
and a greater prevalence of coronary artery disease (82% 
versus O%, p < O.OOOl), structural heart disease and a 
history of clinical sustained ventrical arrhythmias. 
Programmed ventricular stimulation is a useful technique in 
the evaluation of patients with ventricular tachyarrhythmias. 
The most widely accepted end point of ventricular stimula- 
tion has been the induction of sustained ventricular tachy- 
cardia similar in rate and configuration to the clinical 
arrhythmia (l-6). However, in patients whose clinical 
arrhythmia is rapid ventricular tachycardia or ventricular 
fibrillation, the induction of a sustained arrhythmia often 
results in a very fast, hemodynamically unstable rhythm, 
requiring cardioversion for termination (2,7-9). 
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Similarly, the induced self-terminating ventricular 
tachycardia differed in Group A and Group B patients. The 
arrhythmias in Group B patients were more often mono- 
morphic, were more often induced with one or two extrasti- 
muli and had a longer cycle length than those in Group A 
patients. In Group B patients, the electrophysiologic char- 
acteristics of the self-terminating and the sustained induced 
ventricular tachycardias were similar. Cardioversion was 
required in 50% of Group B patients compared with 27% 
of Group C patients (p = 0.038). 
Thus, induction of rapid self-terminating ventricular 
tachycardia in patients with coronary artery disease reli- 
ably predicts subsequent induction of sustained ventricular 
tachycardia of similar rate and configuration. Use of rapid 
self-terminating ventricular tachycardia as an electrophy 
siologic study end point in patients with corormry artery 
disease and documented or suspected ventricular arrhyth- 
mias will substantially reduce the need for cardioversion. 
(J Am Co11 Cardiol1989;13:385-90) 
Self-terminating ventricular tachycardia is often induced 
by programmed ventricular stimulation. The relation of this 
induced tachycardia to clinical and induced sustained ven- 
tricular arrhythmias is not clear. Although self-terminating 
ventricular tachycardia is often considered to be a nonspe- 
cific electrophysiologic finding (l-3,10-12), some investiga- 
tors (13-16) have found it to be of prognostic importance. 
This study prospectively evaluated the significance of 
induced self-terminating ventricular tachycardia by examin- 
ing the clinical and electrophysiologic characteristics of 
three cohorts of patients: those with a maximal response of 
induced rapid self-terminating ventricular tachycardia 110 
beats in duration, those with induced rapid self-terminating 
ventricular tachycardia preceding sustained ventricular 
tachycardia and those with induced sustained ventricular 
tachycardia without preceding rapid self-terminating ventric- 
ular tachycardia. 
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Table 1. Clinical Arrhythmias in 115 Patients 
Group A Group B Group c 
Symptomatic complex VEA 2 (18%) 2 (9%) 2 (2%) 
Nonsustained VT I (64%) 6 (27%) 21 (26%) 
Sustained VT I (9%) 7 (32%) 39 (48%) 
Ventricular fibrillation I (9%) 7 (32%) 20 (24%) 
Total no. of patients II 22 82 
VEA = ventricular ectopic activity; VT = ventricular tachycardia. 
Methods 
Study patients. Between January 1985 and June 1987, 
consecutive patients who underwent electrophysiologic 
study in the antiarrhythmic drug-free state for the evaluation 
of documented or suspected ventricular arrhythmias were 
prospectively enrolled in this study if they had 1) induced 
sustained ventricular tachycardia, or 2) induced rapid self- 
terminating ventricular tachycardia (mean cycle length 5250 
ms and r 10 beats in duration). One-hundred fifteen patients 
were classified into three groups on the basis of their 
electrophysiologic study results. Group A (11 patients) had 
induced rapid self-terminating ventricular tachycardia as the 
maximal response despite protocol completion. Group B (22 
patients) had induced rapid self-terminating ventricular 
tachycardia and subsequently developed sustained ventric- 
ular tachycardia with further stimulation. Group C (82 pa- 
tients) had induced sustained ventricular tachycardia that 
was not preceded by induced rapid self-terminating ventric- 
ular tachycardia. 
Indications for electrophysiologic study were 1) clinical 
sustained ventricular arrhythmias not associated with acute 
myocardial infarction, significant electrolyte abnormalities 
or unstable angina; 2) frequent ventricular ectopic activity or 
nonsustained ventricular tachycardia associated with 
presyncope or syncope; or 3) nonsustained ventricular 
tachycardia in patients with significant organic heart disease 
and reduced left ventricular function (Table 1). The diagno- 
sis of coronary artery disease was made by a documented 
history of myocardial infarction or by cardiac catheterization 
findings. The absence of coronary artery disease was deter- 
mined by clinical history, normal coronary angiograms, a 
negative exercise thallium test or a negative exercise toler- 
ance test. 
Electrophysiologic study protocol. After the patients gave 
written informed consent, they underwent electrophysiolo- 
gic studies in the postabsorptive state after discontinuation 
of antiarrhythmic medication for at least 5 half-lives. No 
patient had received amiodarone for at least 4 months. Our 
stimulation protocol has previously been reported in detail 
(17). One, two and three ventricular premature extrastimuli 
were delivered during drive runs at cycle lengths of 600 and 
400 ms. Stimulation was performed at the right ventricular 
apex and outflow tract. The stimulus strength was twice 
diastolic threshold, and the pulse width was 1 .O ms. The end 
point of the protocol was the induction of sustained ventric- 
ular tachycardia or all premature extrastimuli brought to 
refractoriness. 
Definitions. For the purpose of this investigation, in- 
duced self-terminating ventricular tachycardia was defined 
as ventricular tachycardia with well defined surface and 
endocardial electrograms with a mean cycle length 5250 ms 
and a duration 2 10 beats. Induced self-terminating ventric- 
ular tachycardias that did not meet these rate and duration 
criteria were not analyzed. 
Induced sustained ventricular tachycardia was dejned as 
ventricular tachycardia that lasted 230 s or required inter- 
vention for termination because of significant hemodynamic 
compromise. Ventricular fibrillation was defined as a totally 
disorganized rhythm without well defined surface QRS com- 
plexes. 
Analysis of ventricular tachycardia. Ventricular tachy- 
cardia configuration was analyzed in a blinded fashion by 
three electrophysiologists. Monomorphic ventricular tachy- 
cardia had a uniform QRS in the monitored leads (I, aVF, 
V,, V,) after the first three beats of ventricular tachycardia. 
Polymorphic ventricular tachycardia had a change in axis of 
>45” or a change in QRS amplitude of >50% in any plane. 
Equilibrium radionuclide angiograpby. This procedure 
was performed as previously described (18). Radionuclide 
angiograms were analyzed for left ventricular ejection frac- 
tion and the presence of left ventricular aneurysm without 
knowledge of clinical history or electrophysiologic study 
results. 
Statistics. Data were analyzed by Fisher’s exact test and 
Student’s t test (two-tailed) with use of the CLINFO com- 
puter resource. Comparisons were made between Group A 
and Group B and between Group B and Group C. Signifi- 
cance is defined as p < 0.05, and data are expressed as mean 
” SD. 
Results 
Clinical characteristics (Table 2). Patients whose induced 
sustained ventricular tachycardia was preceded by induced 
self-terminating ventricular tachycardia (Group B) and pa- 
tients who had only induced sustained ventricular tachycar- 
dia (Group C) during electrophysiologic study were remark- 
ably similar in all clinical characteristics. In contrast, Group 
B patients differed distinctly from those patients with in- 
duced self-terminating ventricular tachycardia as the maxi- 
mal response (Group A). Although no Group A patient had a 
history of myocardial infarction or coronary artery disease, 
82% of Group B patients had coronary artery disease (p < 
0.0001) and 77% had a history of myocardial infarction (p < 
0.0001). 
All Group B patients had structural heart disease, 
whereas 36% of Group A patients had a normal heart (p = 
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Table 2. Clinical Characteristics of I I5 Patients 
Group A 
(rl = II) p Value 
Group B 
(n = 22) p Value 
Group C 
(n = 82) 
Age (yrl 
Gender (male) 
Presence of CAD 
History of Ml 
Presence of CM 
Valvular disease 
No structural heart disease 
LVEF (%) 
Clinical sus VTiVF 
62k IS 
8 (73%) 
0 (0%) 
0 (0%) 
3 (27%) 
3 (27%) 
4 (36%) 
52 f 17 
2 (IS’%,) 
NS 
NS 
<O.OOOl 
<O.OOOl 
NS 
NS 
0.008 
0.004 
0.026 
63 2 II 
IX (82%) 
IX (X?(r) 
I7 (7741 
2 (970 
2 (9%) 
0 (0%) 
33 + I3 
I4 (64%) 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
62 ? I4 
73 (89%) 
65 (79%) 
65 176%) 
x ( IO’ii) 
3 (4%) 
3 (4”;) 
30 + I4 
59 (7’Ci) _, 
CAD = coronary artery disease; CM = cardiomyopathy: LVEF = left ventricular ejection fraction: MI = 
myocardial infarction: NS = nonsignificant: SW VT = sustained ventricular tachycardia; VF = ventricular 
fibrillation. 
0.008). Group B patients had greater left ventricular dysfunc- 
tion, as measured by left ventricular ejection fraction, than 
did Group A patients (32 2 13 versus 52 2 17%, p = 0.004). 
Compared with Group A patients, more Group B patients 
had a history of sustained clinical ventricular arrhythmias 
(64 versus 18%, p = 0.026). Thirteen of the 14 Group B 
patients with both clinical and induced sustained ventricular 
arrhythmias had coronary artery disease. 
When the clinical characteristics of all patients with 
induced rapid self-terminating ventricular tachycardia 
(Groups A and B) were examined, all I8 patients with 
coronary artery disease but only 4 (27%) of the 15 patients 
without coronary artery disease had sustained ventricular 
tachycardia after the induction of self-terminating ventricu- 
lar tachycardia (p < 0.0001). This occurred in 14 (88%) of the 
I6 patients with a history of clinical sustained ventricular 
arrhythmias and 8 (47%) of the I7 patients without clinical 
sustained ventricular arrhythmias (p = 0.03). 
Electrophysiologic characteristics of induced self- 
terminating ventricular tachycardia in Group A and Group B 
patients (Table 3). The electrophysiologic characteristics of 
the induced self-terminating ventricular tachycardia in 
Table 3. Electrophysiologic Study Findings in Group A Versus 
Group B Patients With Self-Terminating Ventricular Tachycardia 
Group A Group B 
(n = II) (n = 22) p Value 
Self-terminating vr 0 ((I<+) 9 (41%) 0.015 
induced with 52 PES 
Cl of last PES (msJ IYX z 20 ??I t 31 0.029 
Self-terminating VT 
Mean CL (ms) 200 i: 35 226 5 I6 0.008 
Minimal CL (msk 188 i- I6 206 2 23 0.028 
Monomorphic (no.) ICY%) I2 (55%) 0.022 
RV ERP (mr) 258 i- 23 257 k I9 NS 
Cl = coupling interval: CL = cycle length; NS = nonsignificant: PES = 
programmed extrabtimuli: RV ERP =z right ventricular effective refractory 
period; VT - ventricular tachycardia. 
Group A and Group B patients were remarkably different. 
Although 41% of Group B patients had self-terminating 
ventricular tachycardia induced with only one or two pre- 
mature extrastimuli, in Group A patients all self-terminating 
ventricular tachycardias required three premature extrasti- 
muli for induction (p = 0.015). The self-terminating ventric- 
ular tachycardia in Group A patients was induced with 
shorter coupling intervals (198 ? 20 versus 221 + 31 ms. p = 
0.029). had shorter mean tachycardia cycle lengths (200 + 35 
versus 226 -+ I6 ms, p = 0.008) and had a shorter minimal 
tachycardia cycle length (188 ? 16 versus 206 f 23 ms, p = 
0.028) than that in the Group B patients. Only 9% of Group 
A patients had monomorphic self-terminating ventricular 
tachycardia induced compared with 55% of Group B patients 
(p = 0.022). 
Electrophysiologic characteristics of induced self- 
terminating and sustained ventricular tachycardias in Group 
B patients (Table 4). The electrophysiologic characteristics 
of both the induced self-terminating and the sustained ven- 
tricular tachycardias in Group B patients were similar. 
Specifically, the mean cycle length of the induced self- 
terminating and induced sustained ventricular tachycardias 
(226 t 16 versus 226 t 34 ms, p = NS) were similar, and 
55% of both induced self-terminating and sustained ventric- 
ular tachycardias were monomorphic. When the morpho- 
Table 4. Characteristics of Induced Self-Terminating Versus 
Sustained Ventricular Tachycardia in the 22 Group B Patients 
Induced VT 
Self-Terminating 
Induction with 52 PES 9 (41%) 
CI of last PES (ms) ??I i 31 
VT 
Mean CL (ms) 226 _+ I6 
Minimal CL (ms) 206 + 73 - -_ 
Monomorphic (no.) I2 (55%) 
Abbreviation\ as in Table 3. 
Sustained 
6 (27%) 
126 t 35 
226 k 34 
203 + 24 
I2 (55%) 
p Value 
NS 
NS 
NS 
NS 
NS 
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Table 5. Electrophysiologic Study Findings in Group B Versus 
Group C Patients With Induced Sustained Ventricular 
Tachycardia 
Group B Group c 
(n = 22) (n = 82) p Value 
Sustained VT induced with 52 PES 6 (27%) 42 (51%) 0.045 
CI of last PES (ms) 227 2 35 244 t 39 NS 
Sustained VT 
Mean CL (ms) 226 + 34 282 f 61 <O.OOl 
Minimal CL (ms) 203 + 24 267 t 66 <O.OOl 
Monomorphic 55% 12% NS 
Cardioversion required II (50%) 22 (27%) 0.038 
RV ERP (ms) 257 ? 19 262 c 24 NS 
Abbreviations as in Tables 2 and 3. 
logic features of the induced self-terminating ventricular 
tachycardias and that of the induced sustained ventricular 
tachycardias were compared in a given patient, 82% of the 
arrhythmias were of similar configuration. 
Electrophysiologic characteristics of induced sustained ven- 
tricular tachycardia in Group B and Group C patients (Table 
5). The mean and minimal induced sustained ventricular 
tachycardia cycle lengths were shorter in Group B patients 
than in Group C patients. Although 51% of Group C patients 
had the sustained arrhythmias induced with one or two 
premature extrastimuli, this was only the case in 27% of 
Group B patients (p = 0.045). Group B patients required 
cardioversion of their induced arrhythmias more frequently 
than did Group C patients (50 versus 27%, p = 0.038). There 
were no differences in the proportion of patients with in- 
duced monomorphic ventricular tachycardia or in the cou- 
pling interval of the last extrastimulus that resulted in 
arrhythmia induction in the Group B and Group C patients. 
Discussion 
Self-terminating induced ventricular tachycardia in pa- 
tients with coronary artery disease. This study demonstrates 
that in patients with a history of myocardial infarction or 
coronary artery disease, the induction of 210 beats of 
self-terminating ventricular tachycardia with a mean cycle 
length of 5250 ms reliably predicts the subsequent induction 
of sustained ventricular tachycardia when the stimulation 
protocol is continued. Furthermore, each patient’s induced 
self-terminating and sustained ventricular tachycardias were 
remarkably similar in configuration and rate. In contrast, in 
patients without coronary artery disease in whom self- 
terminating ventricular tachycardia is induced, only 27% 
developed sustained ventricular tachycardia when the stim- 
ulation protocol was completed. Self-terminating ventricular 
tachycardia also predicted the induction of sustained ven- 
tricular tachycardia in patients with a history of clinical 
sustained ventricular arrhythmias, although the correlation 
was much weaker than that for coronary artery disease (p = 
0.03 versus p < 0.0001). Clinical sustained ventricular 
arrhythmias may not be an independent predictor because all 
but one patient with such arrhythmias who had induction of 
both self-terminating and sustained ventricular tachycardias 
also had coronary artery disease. Thus, in patients with 
coronary artery disease, the induction of self-terminating 
ventricular tachycardia meeting these criteria appears to be 
equivalent to the induction of sustained ventricular tachy- 
cardia. 
Clinical and electrophysiologic variables in the three pa- 
tient groups. Clinically, Group B and Group C patients 
were very similar. It was expected that the Group B patients 
would have faster induced sustained ventricular tachycardia 
than Group C patients because, by definition, the former 
group had rapid induced self-terminating ventricular tachy- 
cardia. The balance between slow conduction and recovery 
of excitability is more tenuous in rapid reentrant arrhyth- 
mias, making self-terminating episodes more likely than in 
those patients with a slower tachycardia. The shorter ven- 
tricular tachycardia cycle length in Group B patients may 
reflect anatomically smaller circuits that require three pre- 
mature extrastimuli for the development of sustained reen- 
try. In contrast, the electrophysiologic and clinical variables 
in Group A and Group B patients were markedly different. 
One-third of the Group A patients (inducible rapid self- 
terminating ventricular tachycardia only) had a normal heart 
and a normal mean left ventricular ejection fraction, and the 
induction of self-terminating ventricular tachycardia re- 
quired more aggressive stimulation. The induction of rapid 
self-terminating ventricular tachycardia with one or two 
premature extrastimuli appears to be predictive of subse- 
quent sustained ventricular tachycardia induction because 
all patients in Group A had the tachycardia induced with 
three premature extrastimuli. 
Multiple studies (1,3,10-13) have shown that self- 
terminating ventricular tachycardia is frequently induced in 
patients undergoing electrophysiologic studies who have 
coronary or structural heart disease. The frequency of 
induction of self-terminating ventricular tachycardia in the 
present investigation is not directly comparable with that in 
these earlier studies. Only patients whose induced arrhyth- 
mias met the rate and duration criteria were included in our 
investigation. Most Group C patients (sustained ventricular 
tachycardia only) had coronary artery disease, and many of 
them had episodes of induced self-terminating ventricular 
tachycardia that were <lo beats in duration or had a mean 
cycle length >250 ms. 
Polymorphic ventricular tachycardia. The induction of 
monomorphic sustained ventricular tachycardia in patients 
with documented or suspected sustained ventricular arrhyth- 
mias is widely considered to be a highly specific finding (l- 
4). However, the clinical significance of induced self- 
terminating ventricular tachycardia, particularly when it is 
polymorphic, is controversial (l-3,10-12,19-22). In Group 
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B, 45% of patients had induced self-terminating polymorphic 
ventricular tachycardia, and 90% of these patients had 
coronary artery disease. After further stimulation, all Group 
B patients developed sustained ventricular tachycardia, and 
45% of these sustained arrhythmias were polymorphic. In 
the seven patients with induced polymorphic self- 
terminating ventricular tachycardia whose clinical arrhyth- 
mias were available for analysis, six had clinical arrhythmias 
that were demonstrated to be polymorphic, supporting the 
clinical relevance of induced polymorphic ventricular tachy- 
cardia in these patients. In addition, although degeneration 
to ventricular fibrillation eventually occurred in several 
patients, no patient had ventricular fibrillation as the initial 
induced arrhythmia. 
Other investigations have also examined induced poly- 
morphic self-terminating ventricular tachycardia. Brugada et 
al. (10) induced polymorphic self-terminating ventricular 
tachycardia (six or more beats) in 46% of patients who had 
neither clinical arrhythmias nor structural heart disease. 
Despite using an aggressive stimulation protocol, including 
up to four premature extrastimuli, they were unable to 
induce sustained polymorphic ventricular tachycardia in 
these patients. Similar to our results, they found that in- 
duced polymorphic sustained ventricular tachycardia ap- 
peared to be a meaningful response in that it was only 
induced in patients with clinical ventricular arrhythmias. 
Likewise, Morady et al. (19), using three premature extrasti- 
muli induced polymorphic self-terminating ventricular 
tachycardia (six or more beats) in 12% of patients without 
clinical ventricular arrhythmias. Sustained polymorphic ven- 
tricular tachycardia was not induced in any of their patients. 
Buxton et al. (2) induced polymorphic self-terminating 
ventricular tachycardia (six or more beats) in 19% of patients 
without clinical ventricular arrhythmias and sustained poly- 
morphic ventricular tachycardia in only 3% of their patients. 
These investigators also found that polymorphic self- 
terminating ventricular tachycardia was commonly induced 
in patients with clinical arrhythmias (it was induced in 18% 
of their patients with documented clinical monomorphic 
ventricular tachycardia). Mann et al. (12) were not able to 
induce sustained polymorphic ventricular tachycardia in any 
of 68 patients without clinical arrhythmias despite the use of 
up to four premature extrastimuli. We have extended these 
findings by demonstrating that, in patients with coronary 
artery disease and documented or suspected clinical arrhyth- 
mias, induced self-terminating ventricular tachycardia, 
regardless of its configuration. is a significant finding because 
it reliably predicts induction of sustained ventricular tachy- 
cardia. In contrast, this arrhythmia is not predictive in 
patients without coronary artery disease. 
Limitations of study. We only examined self-terminating 
ventricular tachycardia that met the specific criteria of 
having a duration 210 beats and a cycle length 5250 ms. It 
is possible that other criteria might be as effective in deter- 
mining a meaningful study end point. We only studied 
patients with known or suspected ventricular arrhythmias 
and, thus, our conclusions may not be applicable to patient 
groups without clinical arrhythmias. Lastly, a variety of 
definitions of polymorphic ventricular tachycardia were used 
in other studies (1,2,12). Our definition is similar to that of 
Torres et al. (13) and we believe it is a concise and 
reproducible definition. 
Clinical implications. We have found that, in patients 
with coronary artery disease and documented or suspected 
clinical arrhythmias, the induction of rapid self-determining 
ventricular tachycardia reliably predicts the subsequent in- 
duction of sustained ventricular tachycardia of similar rate 
and configuration. Thus, in patients with coronary artery 
disease, the induction of rapid self-terminating ventricular 
tachycardia appears to be a significant response and may be 
utilized as an electrophysiologic study end point. When 
sustained ventricular tachycardia was subsequently induced, 
it required cardioversion in 50% of the patients. The use of 
self-terminating ventricular tachycardia as an electrophysio- 
logic study end point in patients with coronary artery disease 
will substantially reduce the need for cardioversion. 
Although not directly addressed by this study, our find- 
ings may also have implications for drug efficacy trials. In 
the drug-free state, the induction of rapid self-terminating 
ventricular tachycardia meeting our criteria appears to be an 
electrophysiologic response similar to that of the induction 
of sustained ventricular tachycardia in patients with coro- 
nary artery disease. The relation between induced self- 
terminating ventricular tachycardia and sustained ventricu- 
lar tachycardia after pharmacologic administration is not 
clear. However. the findings of this investigation raise the 
concern that the conversion of inducible sustained ventric- 
ular tachycardia to inducible rapid self-terminating ventric- 
ular tachycardia after antiarrhythmic drug administration 
may not represent a significant clinical improvement. This 
warrants further investigation. 
We are indebted to Antoinette V.B. Tyndall. MSN for expert assistance in 
performing the electrophysiologic studies. and to Barry L. Zaret. MD for 
reviewing the manuscript. 
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